LifeScan said yesterday that it entered into an agreement with Willis Towers Watson to expand the commercialization of its OneTouch Reveal Plus digital diabetes therapy system.
The companies hope the collaboration will see LifeScan and Willis Towers Watson combine to support self-insured employers in helping their employees and dependents manage diabetes.
The OneTouch Reveal Plus is indicated for use with adult patients who have Type 2 diabetes. The device is designed to provide patients with individualized, real-time feedback and virtual coaching, based on a specific treatment plan. It also offers weekly challenges, meal planning tools, an insulin calculator, connectivity with popular fitness trackers and a comprehensive smart visit report for sharing with a healthcare team.